Connection

ZHAOYONG HU to Male

This is a "connection" page, showing publications ZHAOYONG HU has written about Male.
Connection Strength

0.197
  1. Reprogramming of cis-regulatory networks during skeletal muscle atrophy in male mice. Nat Commun. 2023 10 18; 14(1):6581.
    View in: PubMed
    Score: 0.029
  2. Long-noncoding RNA Atrolnc-1 promotes muscle wasting in mice with chronic kidney disease. J Cachexia Sarcopenia Muscle. 2018 10; 9(5):962-974.
    View in: PubMed
    Score: 0.020
  3. Myokine mediated muscle-kidney crosstalk suppresses metabolic reprogramming and fibrosis in damaged kidneys. Nat Commun. 2017 11 14; 8(1):1493.
    View in: PubMed
    Score: 0.019
  4. The nuclear phosphatase SCP4 regulates FoxO?transcription factors during muscle wasting?in chronic kidney disease. Kidney Int. 2017 08; 92(2):336-348.
    View in: PubMed
    Score: 0.018
  5. Suppression of muscle wasting by the plant-derived compound ursolic acid in a model of chronic kidney disease. J Cachexia Sarcopenia Muscle. 2017 Apr; 8(2):327-341.
    View in: PubMed
    Score: 0.018
  6. CKD Stimulates Muscle Protein Loss Via Rho-associated Protein Kinase 1 Activation. J Am Soc Nephrol. 2016 Feb; 27(2):509-19.
    View in: PubMed
    Score: 0.016
  7. Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486. Kidney Int. 2012 Aug; 82(4):401-11.
    View in: PubMed
    Score: 0.013
  8. Integrative transcriptome analysis reveals TEKT2 and PIAS2 involvement in diabetic nephropathy. FASEB J. 2022 11; 36(11):e22592.
    View in: PubMed
    Score: 0.007
  9. Signal regulatory protein alpha initiates cachexia through muscle to adipose tissue crosstalk. J Cachexia Sarcopenia Muscle. 2019 12; 10(6):1210-1227.
    View in: PubMed
    Score: 0.005
  10. Inhibition of hyperglycolysis in mesothelial cells prevents peritoneal fibrosis. Sci Transl Med. 2019 06 05; 11(495).
    View in: PubMed
    Score: 0.005
  11. SCP4 Promotes Gluconeogenesis Through FoxO1/3a Dephosphorylation. Diabetes. 2018 01; 67(1):46-57.
    View in: PubMed
    Score: 0.005
  12. Pharmacological Inhibition of PTEN Aggravates Acute Kidney Injury. Sci Rep. 2017 08 25; 7(1):9503.
    View in: PubMed
    Score: 0.005
  13. The IL-4 receptor a has a critical role in bone marrow-derived fibroblast activation and renal fibrosis. Kidney Int. 2017 12; 92(6):1433-1443.
    View in: PubMed
    Score: 0.005
  14. AMP-activated protein kinase/myocardin-related transcription factor-A signaling regulates fibroblast activation and renal fibrosis. Kidney Int. 2018 01; 93(1):81-94.
    View in: PubMed
    Score: 0.005
  15. Adiponectin promotes monocyte-to-fibroblast transition in renal fibrosis. J Am Soc Nephrol. 2013 Oct; 24(10):1644-59.
    View in: PubMed
    Score: 0.004
  16. Genetic deficiency of adiponectin protects against acute kidney injury. Kidney Int. 2013 Apr; 83(4):604-14.
    View in: PubMed
    Score: 0.003
  17. Deletion of scavenger receptor A protects mice from progressive nephropathy independent of lipid control during diet-induced hyperlipidemia. Kidney Int. 2012 May; 81(10):1002-1014.
    View in: PubMed
    Score: 0.003
  18. Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease. FASEB J. 2011 May; 25(5):1653-63.
    View in: PubMed
    Score: 0.003
  19. Pharmacological inhibition of PTEN limits myocardial infarct size and improves left ventricular function postinfarction. Am J Physiol Heart Circ Physiol. 2010 Apr; 298(4):H1198-208.
    View in: PubMed
    Score: 0.003
  20. Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile. Endocrinology. 2008 Feb; 149(2):827-35.
    View in: PubMed
    Score: 0.002
  21. Development of a diagnostic method for detecting increased muscle protein degradation in patients with catabolic conditions. J Am Soc Nephrol. 2006 Nov; 17(11):3233-9.
    View in: PubMed
    Score: 0.002
  22. Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology. 2006 Sep; 147(9):4160-8.
    View in: PubMed
    Score: 0.002
  23. Chronic kidney disease causes defects in signaling through the insulin receptor substrate/phosphatidylinositol 3-kinase/Akt pathway: implications for muscle atrophy. J Am Soc Nephrol. 2006 May; 17(5):1388-94.
    View in: PubMed
    Score: 0.002
  24. Regulation of muscle protein degradation: coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase. J Am Soc Nephrol. 2004 Jun; 15(6):1537-45.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.